As of April 2024 Onconova Therapeutics has a market cap of $20.9 Million. This makes Onconova Therapeutics the world's 7971th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $20.9 M | 33.49% |
2023 | $15.66 M | 15.9% |
2022 | $13.51 M | -74.64% |
2021 | $53.27 M | -38.16% |
2020 | $86.14 M | 102.34% |
2019 | $42.57 M | 255.62% |
2018 | $11.97 M | -25.9% |
2017 | $16.15 M | 5.29% |
2016 | $15.34 M | -37.02% |
2015 | $24.36 M | -65.88% |
2014 | $71.4 M | -71.03% |
2013 | $0.24 B |
On Apr 24th, 2024 the market cap of Onconova Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Baxter BAX | $20.84 B | 99,626.80% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.21 B | 911.27% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $1.19 B | 5,634.55% | ๐บ๐ธ USA |
Cleveland BioLabs
CBLI | $49.06 M | 134.72% | ๐บ๐ธ USA |
Array Technologies ARRY | $1.85 B | 8,776.58% | ๐บ๐ธ USA |